Humira is given once every other week or sometimes every week. The dosage is normally 40 milligrams (mg). However, in the ...

Merck’s Keytruda holds on to the top spot while AbbVie’s Humira—once the world’s top-selling drug—continues to cede its ...

Effectiveness between the adalimumab biosimilars (Amjevita and Imraldi) and the original brand-name version (Humira) was comparable both in new users and for patients switching from the original ...

Shares of AbbVie (NYSE: ABBV) fell hard in the wake of its Q1 earnings report, but the dip is over. The market response to slowing Humira sales is overshadowed by strength in the non-Humira portfolio, ...

but only for the lower concentrations (40 mg/0.8 mL or 20 mg/0.4 mL) of Humira. Most are, however, working to get interchangeable status for their biosimilars, and three of them – Organon ...

Novartis' Sandoz division has filed its biosimilar of Humira in the US, aiming to take a share of its multi-billion dollar revenues once its patent expires. The generics and biosimilars arm of ...

Amjevita contains the active ingredient adalimumab-atto and is a biosimilar of the brand-name drug Humira (adalimumab). The “-atto” appears at the end of Amjevita’s name to show it’s ...